Headlands Technologies LLC Raises Stock Holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO)

Headlands Technologies LLC raised its holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO – Free Report) by 31.3% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 9,037 shares of the biopharmaceutical company’s stock after acquiring an additional 2,153 shares during the quarter. Headlands Technologies LLC’s holdings […]

Related Keywords

China ,Hong Kong ,James William Burns ,Brian Goff ,Goldman Sachs Group ,Agios Pharmaceuticals Stock Performance ,Quarter For Agios Pharmaceuticals ,Agios Pharmaceuticals Inc ,Tower Research Capital ,Headlands Technologies ,China Universal Asset Management Co ,Hong Kong Ltd ,Agios Pharmaceuticals Company Profile ,Securities Exchange Commission ,Cantor Fitzgerald ,Agios Pharmaceuticals ,Nasdaq ,Ameritas Investment Partners Inc ,Lazard Asset Management ,News Ratings For Agios Pharmaceuticals Daily ,Free Report ,Universal Asset Management ,Kong Ltd ,Research Capital ,Asset Management ,Ameritas Investment Partners ,Investment Partners ,Exchange Commission ,Agios Pharmaceuticals Daily ,Nasdaq Agio ,Plagio ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,